Biotech Fluidics has expanded its family of non-invasive flowmeters for real-time monitoring of liquid flow. The range now includes four discrete devices optimized to …
BIO-Europe® has grown to be recognized as Europe’s flagship partnering event. In 2022, the event made its highly anticipated return to in-person, after a two-year …
The Food and Drug Administration’s decision last month not to approve a new treatment for one of the most common forms of depression was, in …
Dive Brief: Roche on Friday said one of its medicines succeeded in a Phase 3 trial of people whose lung tumors were driven by a …
Dive Brief: Sanofi has found a new head of research and development in Houman Ashrafian, who currently serves as a scientific advisor at SV Health …
Dive Brief: Sage Therapeutics, reeling from a regulatory decision that will sharply curtail the potential of its newest medicine, is slashing jobs, pausing some early-stage …
The pharmaceutical industry’s counterattack against Medicare’s new drug pricing powers widened Friday with AstraZeneca joining several of its drugmaker peers in suing the U.S. government. …
Pharmaceutical giant Merck & Co. has begun late-stage testing of a cholesterol pill it hopes could be its next big heart medicine. The company on …
A closely watched, experimental Roche medicine may be helping lung cancer patients live longer, spurring renewed optimism about an emerging class of immunotherapy treatments. The …
Dive Brief: Neumora Therapeutics on Friday filed plans for an initial public offering, one month after announcing it would soon begin late-stage testing for a …
Dive Brief: A drug combination involving Gilead’s antibody medicine Trodelvy shrank or eliminated tumors in just over half of the lung cancer patients who received …
One of Merck & Co.’s already marketed drugs has generated positive results in a large clinical trial testing it in patients with a hard-to-treat form …
Dive Brief: Moderna on Thursday said the updated COVID shot it’s preparing ahead of a fall vaccination campaign can neutralize two new coronavirus strains, among …
Dive Brief: After years of fits and starts, Ipsen won Food and Drug Administration approval to sell the first treatment for a rare disease known …
The exhibition centre hosts the international event – renowned as ‘the heart of pharma’ – in Europe’s premier pharma manufacturing region CPHI, the world’s largest …
Novo Nordisk is hiking projections for its fast-selling diabetes and obesity drugs even higher following results showing one of them, Wegovy, can reduce the risk …
The family of Henrietta Lacks is suing rare disease drug developer Ultragenyx over its use of technology built from her cells, which were taken without …
Dive Brief: The Food and Drug Administration has conditionally approved a new medicine for multiple myeloma, offering patients with hard-to-treat forms of the blood cancer …
Dive Brief: Novo Nordisk agreed to buy metabolic disorder specialist Inversago Pharma in a deal worth as much as about $1.1 billion as the Danish …
Celebrating the innovation, scientific successes, and personal achievements of their community is extremely important to them. ELRIG are proud to be able to showcase posters …
